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Stavros I Tyritzis1,3*, Ioannis Anastasiou1, Konstantinos G Stravodimos1, Aristeides Alevizopoulos1, Anastasios Kollias2,
Antonios Balangas2, Ioannis Katafigiotis1, Ioannis Leotsakos1, Dionysios Mitropoulos1 and
Constantinos A Constantinides1Abstract
Background: Radical cystectomy (RC) is probably underused in elderly patients due to a potential increased
postoperative complication risk, as reflected by their considerable comorbidities. Our objective was to estimate the
overall complication rate and investigate a potential benefit to patients over the age of 75 subjected to RC in terms
of disease-free survival.
Methods: A total of 81 patients, 61 men and 20 women, from two urological departments, with a mean age of
79.2 ± 3.7 years, participated in the study. The mean follow-up period was 2.6 ± 1.6 years. All patients underwent RC
with pelvic lymphadenectomy. An ileal conduit, an orthotopic ileal neobladder and cutaneous ureterostomies were
formed in 48.1%, 6.2% and 45.7% of the patients, respectively. The perioperative and 90-day postoperative
complications were recorded and classified according to the modified Clavien classification system. Survival plots
were created based on the oncological outcome and several study parameters.
Results: The perioperative morbidity rate was 43.2%; the 90-day morbidity rate was 37%, while the 30-day, 90-day and
overall mortality rates were 3.7%, 3.7% and 21%, respectively. Overall mortality rates were recorded at the final year of
data gathering (2009). Increased age, increased body mass index (BMI), longer hospitalization and age-adjusted
Charlson comorbidity index (ACCI) more than six, were associated with greater hazard for 90-day morbidity. The
cumulative mortality / metastasis-free rates for one, two, three and five years were 88.7%, 77.5%, 70.4%, and 62.3%,
respectively. Tumour stage and positive nodes were prognostic predictors for oncological outcome.
Conclusions: RC in patients over 75 is justified and feasible, due to acceptable complication rates and high 5-year
cancer-specific survival, which support an aggressive approach. Prospective studies are needed for the verification of
the above results.
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comorbidity indexBackground
Muscle-invasive bladder cancer incidence increases with
age and peaks in the octogenarians [1,2]. Even though rad-
ical cystectomy (RC) is the gold standard for this disease
[3], it is underused and possibly inappropriately denied,
because the majority of these patients are either unfit for
surgery or have considerable comorbidities. This selection* Correspondence: styritzis@med.uoa.gr
1Department of Urology, Athens University Medical School, LAIKO Hospital,
Athens, Greece
3Department of Urology, Athens University Medical School, LAIKO Hospital,
17 Agiou Thoma str., Athens 11527, Greece
Full list of author information is available at the end of the article
© 2012 Tyritzis et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orbias might preclude a potential effective management in
the older patients [4]. The above argument is further
strengthened by a recent report concluding that bladder-
sparing protocols in octogenarians with> pT2 disease and
American Society of Anesthesiologists (ASA) score 3–4
has a very bad prognosis [5].
Increased surgical experience and improvements in sur-
gical techniques are constantly expanding the indications
for aggressive treatment. This fact provided the rationale
for our study, which attempted to investigate the feasibility
of RC in these high-risk patients and establish a potential
benefit on cancer-specific survival in the long term.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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We reviewed the files of 81 patients, 61 men and 20
women, with a mean age of 79.2 years (SD=3.7 years)
(range 75–95 years). All patients, after providing informed
consent, underwent RC and pelvic lymphadenectomy from
2000 through 2009. Ethical approval was not required due
to the retrospective nature of the study, as stated by our
institutions scientific committee. The clinical and demo-
graphic characteristics of the patients are shown in Table 1.
The indications for RC were muscle invasive disease, non
muscle invasive disease refractory to intravesical chemo-
therapy and/or immunotherapy and palliation treatment for
uncontrolled haemorrhage (in 11 out of 81 patients). No
patient had distant metastasis at the time of the operation.
No patient received neo-adjuvant chemotherapy or radio-
therapy, while 12 (14.8%) and 3 patients (3.7%) received
adjuvant chemotherapy and external beam radiotherapy,
respectively.
Perioperative complications were defined as complica-











BMI, mean (SD) 25.5(3.2)
Urinary diversion
Ileal conduit 39 48.1
S-pouch 5 6.2
Cutaneous ureterostomy 37 45.7
pT (TNM system)
pTis 12 14.8
pT1 to pT2b 28 34.6
pT3a to pT3b 29 35.8








*categorized according to tertiles.
BMI: Body mass index.
SD: Standard deviation.90-day morbidity and mortality were also recorded. The
Martin criteria for standardized reporting of complications
were used [6] (Table 2). The complications were classified
according to the modified Clavien classification system [7]
(Table 3). Follow-up of the patients was performed by
scheduled hospital visits and telephone interviews.
Statistical analysis
Quantitative variables are expressed as mean (±SD) or
as median values (interquartile range). Qualitative vari-
ables are expressed as absolute and relative frequencies.
Life table analyses were used to calculate cumulative sur-
vival rate (standard errors) for specific time intervals. The
prognostic value of each variable was first assessed by
univariate Cox regression analysis. Variables that showed
significant association with the outcome were included in
the multivariate Cox proportional-hazard model in a
stepwise method, in order to determine the independent
predictors for morbidity and oncological outcome. The
assumption of proportional hazards was evaluated by
testing for interaction with a continuous time variable.
Kaplan – Meier survival estimates for soft and hard events









Report clarifies the time period of
postoperative accrual




Study indicates that complications
first identified following
discharge are included in the analysis.
Definitions of complications
provided
Article defines at least one
complication with specific inclusion
criteria.
Mortality rate and causes
of death listed
The number of patients who died
in the postoperative period of study
are recorded together with cause
of death.
Morbidity rate and total
complications indicated
The number of patients with any
complication and the total number
of complications are recorded.
Procedure-specific complications
included
Severity grade utilized Any grading system designed to
clarify severity of complications
including “major and minor”
is reported.
Length-of-stay data Median or mean length of stay
indicated in the study.
Risk factors included in
the analysis
Evidence of risk stratification and
method used indicated by study.
Table 3 Clavien classification of perioperative and 90-day morbidity and mortality
CLAVIEN grade N % N %
No complication 29 35.8
Perioperative morbidity
(0-10d)
35 43.2 90-day morbidity 30 37
1 11 13.6 15 18.6
Any deviation from the normal postoperative course
without the need for pharmacological treatment or
surgical, endoscopic, and radiological interventions.
Allowed therapeutic regimens are: drugs as antiemetics,
antipyretics, analgetics, diuretics, electrolytes, and
physiotherapy. This grade also includes wound infections
opened at the bedside.
Hyperemesis 1 1.2 Pneumonia 2 2.4
Fever 7 8.4 Psoas abscess 1 1.2
Ileus 1 1.2 Wound infection 11 13.6
Pneumonia 1 1.2 Lympocele 1 1.2
Urine leakage 1 1.2
2 22 27.2 4 4.8
Requiring pharmacological treatment with drugs
other than such allowed for grade I complications.
Blood transfusions and total parenteral nutrition
are also included.
Blood transfusion 21 25.9 Wound dehiscense 1 1.2
UTI 1 1.2 UTI 3 3.6
3 1 1.2 6 7.2
Requiring surgical, endoscopic or radiological intervention
3a - - 0 2 2.4
Intervention not under general anesthesia - - 0 Cardiac arrythmia-pacemaker 1 1.2
Obstructive nephropathy 1 1.2
3b 1 1.2 4 4.8
Intervention under general anesthesia Rectal injury, re-operation, colostomy 1 1.2 Evisceration, re-operation 1 1.2
Stricture ileus, re-operation 2 2.4
Incisional hernia 1 1.2
4 1 1.2 2 2.4
Life-threatening complication (including CNS complications)
requiring IC/ICU management
Sepsis 1 1.2 Myocardial Infarction 1 1.2
Sepsis 1 1.2
5 - - 0 3 3.7
Death of a patient Death 3 3.7
30-day (sepsis, pneumonia) 2 2.4
60-day (evisceration, re-operation 1 1.2
90-day 0 0
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p< 0.05 and analyses were conducted using the SPSS
statistical software (version 17.0).
Results
The mean follow-up period was 2.6 ± 1.6 years with
median equal to 2.4 years (interquartile range from 1.2
to 3.9 years). During the follow-up period, the periopera-
tive morbidity rate was 43.2% (N=35), 90-day morbidity
rate was 35.8% (N=29), the perioperative and overall mor-
tality rates were 3.7% and 21.0%, respectively, while 6patients had metastasis (7.4%). In salvage RC, perioperative
morbidity rate was 45.4%, 90-day morbidity rate reached
36.4%, while perioperative mortality was 9%. Positive nodes
were found in 25.9% of the patients. The mean length of
hospitalization was 13.0±7.3 days and 14.8% of the patients
had an age-adjusted Charlson comorbidity index (ACCI)
more than six. Table 4 presents the results of univariate
analysis for the association of study parameters with peri-
operative morbidity. Perioperative morbidity rate was not
significantly different when adjusted to the clinical and
demographic characteristics of the patients. Univariate Cox
Table 4 Demographic and clinical characteristics of the
study group associated with perioperative morbidity
Perioperative morbidity (10 days) Px²
testNo Yes
N % N %
Gender
Male 36 59.0 25 41.0 0.752
Female 11 55.0 9 45.0
Age (years) , mean (SD) 79.3(4.0) 78.9(3.2) 0.650**
Age (years)
<77 14 60.9 9 39.1 0.895
77-80 17 54.8 14 45.2
>80 16 59.3 11 40.7
BMI, mean (SD) 25.6(2.9) 25.5(3.7) 0.873**
Urinary diversion
Ileal conduit 22 56.4 17 43.6 0.724*
S-pouch 4 80.0 1 20.0
Cutaneous ureterostomy 21 56.8 16 43.2
pT (TNM system)
pTis 3 25.0 9 75.0 0.070
pT1 to pT2b 17 60.7 11 39.3
pT3a to pT3b 18 62.1 11 37.9
pT4a to pT4b 9 75.0 3 25.0
Nodes (TNM system)
0 34 56.7 26 43.3 0.675
1-2 13 61.9 8 38.1
Hospital stay, mean (SD) 13.7(8.4) 12.1(5.4) 0.334**
Charlson score
≤6 39 56.5 30 43.5 0.511
>6 8 66.7 4 33.3
*Indicates reference category.
**Hazard ratio cannot be calculated because of no distribution.
Table 5 Univariate and multiple Cox proportional hazards
models for the prediction of 90-day morbidity
Crude Adjusted
HR (95% CI) { P HR (95% CI) P
Gender
Male 1.00*
Female 0.98 (0.42 - 2.28) 0.955
Age (years),
mean ± SD
1.08 (0.99 - 1.17) 0.079
Age (years)
<77 1.00* 1.00*
77-80 4.12 (1.18 - 14.33) 0.026 4.92 (1.35 - 17.95) 0.016
>80 4.04 (1.14 - 14.31) 0.031 5.86 (1.47 - 23.42) 0.012






1.18 (0.57 - 2.44) 0.658
pT (TNM system)
pTis 1.00*
pT1 to pT2b 0.51 (0.18 - 1.42) 0.197
pT3a to pT3b 0.62 (0.23 - 1.72) 0.362
pT4a to pT4b 0.56 (0.16 - 2) 0.377
Nodes (TNM system)
0 1.00*
1-2 1.2 (0.53 - 2.7) 0.665
Hospital stay,
mean ± SD
1.05 (1.02 - 1.09) 0.002 1.06 (1.02 - 1.09) 0.002
Charlson score
≤6 1.00* 1.00*
>6 2.43 (1.03 - 5.7) 0.042 2.51 (1.06 - 5.94) 0.037
{Hazard Ratio (95% Confidence Interval).
*Indicates reference category.
**Hazard ratio cannot be calculated because of no distribution.
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that increased age, increased body mass index (BMI), hos-
pital stay and ACCI more than six, were associated with
greater hazard for 90-day morbidity. When multiple Cox
regression analysis with stepwise-forward approach was
applied (Table 6), it was found that age, BMI, hospital stay
and ACCI were independently associated with morbidity.
Specifically, for one day increase in hospital stay, the mor-
bidity hazard increases by 6%, while for one unit increase
in BMI, the morbidity hazard increases by 18%. Further-
more, patients aged 77 to 80 years and those aged more
than 80 years had greater morbidity hazard compared to
those aged less than 77 years with adjusted hazard ratios
equal to 4.92 and 5.86, respectively. Additionally, subjects
with ACCI more than six had 2.51 times greater morbidity
hazard compared to those with ACCI equal or less than
six. Kaplan Meier morbidity estimations according to
ACCI are presented in Figure 1.The cumulative mortality / metastasis-free rates for
one, two, three and five years were 88.7% [Standard
Error (SE) = 3.6%], 77.5% (SE = 4.8%), 70.4% (SE = 5.5%)
and 62.3% (SE = 7.3%), respectively. Both univariate and
multiple analysis concerning death or metastasis (Table 5)
revealed that tumour stage and nodes were prognostic pre-
dictors for oncological outcome. Specifically, as resulted
from multiple analysis, patients with tumour stage pT4a to
pT4b had 9.19 times greater hazard for death or metastasis
compared to those with in situ tumours. Moreover, patients
with one or two positive nodes had 2.4 times greater hazard
for death or metastasis. Kaplan Meier estimates for death
or metastasis according to tumour stage and nodes are pre-
sented in Figures 2 and 3, respectively.
Discussion
Octogenarians are per se, a high-risk group, due to their
comorbidities. Using the age-adjusted Charlson comorbidity
Table 6 Univariate and multiple Cox proportional hazards
models for the prediction of death/metastasis
Crude Adjusted
HR (95% CI){ P HR (95% CI) P
Gender
Male 1.00*
Female 0.41 (0.12 - 1.4) 0.155
Age (years),
mean ± SD
1 (0.89 - 1.13) 0.976
Age (years)
<77 1.00*
77-80 1.57 (0.57 - 4.34) 0.382
>80 1.06 (0.36 - 3.17) 0.910
BMI, mean ± SD 0.96 (0.84 - 1.1) 0.563
Urinary diversion




1.03 (0.45 - 2.36) 0.944
pT (TNM system)
pTis 1.00* 1.00*
pT1 to pT2b 3.11 (0.37 - 25.88) 0.293 2.87 (0.35 - 23.9) 0.329
pT3a to pT3b 5.5 (0.7 - 43.04) 0.105 5.99 (0.76 - 46.95) 0.088
pT4a to pT4b 9.11 (1.09 - 75.81) 0.041 9.19 (1.10 - 76.58) 0.040
Nodes (TNM system)
0 1.00* 1.00*
1-2 2.52 (1.10 – 5.75) 0.028 2.4 (1.05 - 5.49) 0.039
Hospital stay.
mean ± SD
































Figure 1 Kaplan-Meier curves for 90-day morbidity stratified by age-a
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is added to the total score, a fact that reflects the signifi-
cance of age in the performance status of a patient [8].
Koppie et al recently suggested the association between
ACCI and the clinical and oncological outcome after a RC
[9]. Other authors also reported that postoperative mor-
bidity is higher in patients with higher ASA score and
more than 2 comorbidities [10]. The same conclusion was
reached by a collaborative review, which however, stated
that age alone does not preclude RC in the elderly [11].
Our results of perioperative mortality and 90-day mor-
bidity are comparable to those of the above mentioned
reviews, which range between 0-11% and as high as 64%
[11], respectively, support the notion of an aggressive treat-
ment offered to octogenarians. The 90-day instead of the
30-day or the 60-day morbidity was selected because it is
already established as a more potent and realistic descrip-
tion tool of the postoperative risks of the RC morbidity, as
several reports are suggesting [11,12]. The 90-day morbid-
ity along with the use of the Clavien classification system,
give a distinct advantage in our study in terms of complica-
tion reporting quality [11-13].
The incidence of wound complications was surprisingly
high in our series (11%) and it could be attributed to poor
healing capacity and poor patient hygiene. In order to
avoid this kind of complication, we now routinely use ten-
sion sutures along with Nylon sutures or clips for wound
closure at the end of the operation, which are removed ap-
proximately one month later.
The complication rates did not vary between salvage and
primary RC. The main difference was that perioperative
mortality was significantly higher in the salvage RC (9% vs.
3.7%), which was somewhat expected, due to the nature of60 80 100
fter surgery
Charlson score >6
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Follow-up (months)
Nodes = 0 Nodes = 1-2
Figure 2 Kaplan-Meier curves for event-free probability stratified by nodal status. (p = 0.039).
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the time of the operation. The above observation is in ac-
cordance to other authors [14,15]. Furthermore, obesity
and longer hospital stay have been identified as risk factors
for higher postoperative morbidity.
The selected type of urinary diversion does not seem to
alter the morbidity/mortality outcome, as shown in other
studies as well [11,16]. It is however important to notice,
that high-volume centers, performing> 50 RC’s per year
should be involved in these cases, because the surgical ex-
perience in these centers is more advanced and is asso-
































Figure 3 Kaplan-Meier curves for event-free probability stratified by tdecreased mortality, shorter length of hospital stay and
lower rehospitalization rates [11,17].
Cancer-specific survival is another major concern when
the decision to perform RC in an octogenarian should be
taken, as the reported results are rather controversial. Two
retrospective studies, reviewing a total of approximately
1120 patients have reported unfavourable oncological
outcomes in elderly patients [18,19]. In the first study,
the 5-year was 28.1%, while in the second the 3-year and
7-year cancer-specific survival rates were between 70%
and 55.2%, respectively. On the other hand, Chamie et al




umour stage. (pT1-pT2b: p = 0.329, pT3: p = 0.08, pT4: p = 0.04).
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waiting, or radiotherapy and chemotherapy [4,20]. Chamie
and colleaques also stated that pelvic lymphadenectomy
should be performed in order for RC to show any survival
advantage in the octogenarians [20]. Based on our results,
we advocate RC and lymphadenectomy in the elderly
patients, since the 5-year survival rate in our series was
significantly high (62.3%) and tumour stage and node sta-
tus were prognostic predictors for the oncological out-
come. Clinical tumour stage and grade remain the best
predictors of cancer specific survival [21]. Therefore, it is
imperative for the RC candidates to undergo a meticulous
clinical and imaging examination.
Conclusions
Age should not hamper RC, particularly when it takes
place in specialized, high-volume centers. The reported
complication rates of this particular group of patients,
especially when standardized with validated methodolo-
gies, are acceptable. Strict selection of non obese patients,
with non metastatic disease and an ACCI less than six,
may result in a better postoperative outcome.
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